Primary practice
Find Dr. Deleve's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Deleve practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.
Dr. Deleve's NPI, 1407882947, was assigned on June 25, 2006. Dr. Deleve graduated from Erasmus University Rotterdam Faculty of Medicine in 1979. Dr. Deleve holds California license A44134.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Deleve's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.
Source: Dmand AI Affiliation Data
Dr. Deleve's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Deleve is also affiliated with Los Angeles General Medical Center. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Deleve to 1 more group practice or clinic and 1 urgent care center, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deleve practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Keck Hospital of USC | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Southern California and 6.2K+ hospitals, with verified contacts in the same login.
Gastroenterology is Dr. Deleve's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Deleve is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Deleve's licenses on file in 2 states: California and Michigan.
Dmand AI lists acid reflux, colonoscopy, gastroenteritis and upper GI endoscopy among the conditions Dr. Deleve treats.
Counts of gastroenterologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
CMS data shows 11 Medicare services from Dr. Deleve across 1 procedure code in 2020, for 37 Medicare patients. Medicare paid $53 for them. Every service was in a facility, such as a hospital, rather than an office.
Medians across 1,875 gastroenterologists in California with Dmand AI profiles that report each measure.
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Deleve?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Deleve and other gastroenterologists in California.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
CMS counts 37 Medicare patients who saw Dr. Deleve in 2024. The largest group is 65 to 74, with 12 patients. 73% of them have high blood pressure, and 70% have high cholesterol. 49% are also on Medicaid. Their average risk score is 2.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Deleve's median patient age at 58, with 57% women.
CMS leaves out age groups with fewer than 11 patients.
Share of Medicare patients with each condition. A patient can have several.
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Median age 58
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
In 2024, Dr. Deleve wrote 75 Medicare Part D claims for 30 patients. 72% of them were for generic drugs. CMS names the drug for 46 of them, across 3 drugs with 11 or more claims each, at $10,539 in total drug cost. In 2022, CMS named 11 claims across 1 drug.
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drugs named by CMS: 3 in 2024, 1 in 2022.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Deleve accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Deleve as offering telehealth.
Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)
Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)
Sources: Doctors and Clinicians National Downloadable File (CMS); and Doctors and Clinicians Utilization Data (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dmand AI links 1 paper to Dr. Deleve.
See who Dr. Deleve researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Deleve works with, so you can find a warm path to the right gastroenterologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dmand AI links Dr. Deleve to 2 clinical trials. Conditions studied include Gliosarcoma, Hepatolenticular Degeneration and Glioblastoma. Open Payments lists research payments to Dr. Deleve that name 2 trials.
Conditions in Dr. Deleve's trials
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
CMS Open Payments shows 88 general payments to Dr. Deleve from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 96% of the total. Daiichi Sankyo Inc. paid the most, $139,076. It also lists 2 research payments totaling $6,625 from 2019 to 2020, naming 2 clinical trials.
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Deleve graduated from Erasmus University Rotterdam Faculty of Medicine in 1979.
Source: Dmand AI Professional Profile Data
Dr. Deleve is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and Elevance. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.
Source: Dmand AI Insurance Network Data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
Dr. Laurie Donna Deleve's NPI number is 1407882947. It was assigned on June 25, 2006, and it is active in the NPI Registry.
Dr. Laurie Donna Deleve is a gastroenterologist in Los Angeles, California. The primary specialty in the NPI Registry is Gastroenterology Physician (taxonomy code 207RG0100X).
Dr. Deleve practices at 1500 San Pablo Street, Los Angeles, CA 90033. Dr. Deleve's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dmand AI also links Dr. Deleve to 1 group practice or clinic and 1 urgent care center.
The practice phone on file for Dr. Deleve is (323) 442-8656.
Dr. Deleve holds California license A44134, one of the licenses on file in 2 states.
Dmand AI has state licenses on file for Dr. Deleve in California (1987 to 2027) and Michigan (1986 to 1996).
Dr. Deleve practices at Keck Hospital of USC in Los Angeles, California. Dr. Deleve is also affiliated with Los Angeles General Medical Center.
Dr. Deleve is linked to USC Care Medical Group.
Yes. CMS data shows Dr. Deleve billed Medicare for 11 services in 2020, and Dr. Deleve accepts Medicare assignment.
Yes. The CMS Doctors and Clinicians file lists Dr. Deleve as offering telehealth services.
CMS counts 37 Medicare patients who saw Dr. Deleve in 2024, with an average age of 69.
Yes. Dr. Deleve is board certified in gastroenterology by the American Board of Internal Medicine.
In 2020, Dr. Deleve's most billed Medicare services were medicare service (G0500).
Dr. Deleve graduated from Erasmus University Rotterdam Faculty of Medicine in 1979.
In 2024 Medicare Part D data, Dr. Deleve's most prescribed drugs by claims were Linzess, Omeprazole and Peg 3350-Electrolyte.
CMS Open Payments shows $168,689 in general payments to Dr. Deleve from 7 companies from 2016 to 2025. The largest total came from Daiichi Sankyo Inc.
Dr. Deleve graduated from medical school in 1979, 47 years ago.
Dmand AI links 1 publication to Dr. Deleve. Dr. Deleve has worked on 2 clinical trials.
Dr. Deleve is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and Elevance. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.
Selling to gastroenterology practices?
See gastroenterologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.